Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Arnout

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 21, 2007
Major coagulation disturbances during fractionated plasma separation and adsorptionB K I Meijers, P Verhamme, F Nevens, et al.
Circulation|October 1, 1993
MK-383 (L-700,462), a selective nonpeptide platelet glycoprotein IIb/IIIa antagonist, is active in manK Peerlinck, I De Lepeleire, M Goldberg, et al.
Thrombosis and Haemostasis|July 10, 1998
Comparison of a synthetic antithrombin III-binding pentasaccharide and standard heparin as an adjunct to coronary thrombolysisS V Pislaru, C Pislaru, X Zhu, et al.
Clinical Pharmacology and Therapeutics|October 1, 1994
Pharmacokinetics and pharmacodynamics of MK-383, a selective non-peptide platelet glycoprotein-IIb/IIIa receptor antagonist, in healthy menJ S Barrett, G Murphy, K Peerlinck, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 16, 2002
Dietary habit profile in European communities with different risk of myocardial infarction: the impact of migration as a model of gene-environment interaction. The IMMIDIET StudyL Iacoviello, J Arnout, F Buntinx, et al.
Acta Clinica Belgica|January 1, 1997
Comparative study of antiphospholipid antibody detection in eleven Belgian laboratoriesP Capel, J Arnout, P Cauchie, et al.
Alimentary Pharmacology & Therapeutics|August 29, 2002
Effects of enteric-coated, low-dose aspirin on parameters of platelet functionA Van Hecken, M L Juliano, M Depré, et al.
Journal of Clinical Pharmacology|May 11, 1999
Effect of montelukast on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteersA Van Hecken, M Depré, R Verbesselt, et al.
Nature Medicine|February 15, 2001
Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosisA Angelillo-Scherrer, P de Frutos, C Aparicio, et al.
Blood|March 26, 1999
Antifactor VIII antibody inhibiting allogeneic but not autologous factor VIII in patients with mild hemophilia AK Peerlinck, M G Jacquemin, J Arnout, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 21, 2007
Major coagulation disturbances during fractionated plasma separation and adsorptionB K I Meijers, P Verhamme, F Nevens, et al.
Circulation|October 1, 1993
MK-383 (L-700,462), a selective nonpeptide platelet glycoprotein IIb/IIIa antagonist, is active in manK Peerlinck, I De Lepeleire, M Goldberg, et al.
Thrombosis and Haemostasis|July 10, 1998
Comparison of a synthetic antithrombin III-binding pentasaccharide and standard heparin as an adjunct to coronary thrombolysisS V Pislaru, C Pislaru, X Zhu, et al.
Clinical Pharmacology and Therapeutics|October 1, 1994
Pharmacokinetics and pharmacodynamics of MK-383, a selective non-peptide platelet glycoprotein-IIb/IIIa receptor antagonist, in healthy menJ S Barrett, G Murphy, K Peerlinck, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 16, 2002
Dietary habit profile in European communities with different risk of myocardial infarction: the impact of migration as a model of gene-environment interaction. The IMMIDIET StudyL Iacoviello, J Arnout, F Buntinx, et al.
Acta Clinica Belgica|January 1, 1997
Comparative study of antiphospholipid antibody detection in eleven Belgian laboratoriesP Capel, J Arnout, P Cauchie, et al.
Alimentary Pharmacology & Therapeutics|August 29, 2002
Effects of enteric-coated, low-dose aspirin on parameters of platelet functionA Van Hecken, M L Juliano, M Depré, et al.
Journal of Clinical Pharmacology|May 11, 1999
Effect of montelukast on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteersA Van Hecken, M Depré, R Verbesselt, et al.
Nature Medicine|February 15, 2001
Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosisA Angelillo-Scherrer, P de Frutos, C Aparicio, et al.
Blood|March 26, 1999
Antifactor VIII antibody inhibiting allogeneic but not autologous factor VIII in patients with mild hemophilia AK Peerlinck, M G Jacquemin, J Arnout, et al.
Pageof 10